Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Zai Lab Community
NasdaqGM:ZLAB Community
1
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Zai Lab
Popular
Undervalued
Overvalued
Community Investing Ideas
Zai Lab
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
New VYVGART And Pipeline Advances Will Expand Global Markets
Key Takeaways Strong revenue growth is expected due to robust product launches and pipeline innovations, with profitability anticipated through cost optimization and operational efficiencies. Expanding prescriber networks and enhancing patient access strategies are likely to drive sales and patient adoption, bolstering overall earnings.
View narrative
US$54.87
FV
43.2% undervalued
intrinsic discount
47.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
ZLAB
ZLAB
Zai Lab
Your Fair Value
US$
Current Price
US$31.18
11.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-704m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.4b
Earnings US$293.5m
Advanced
Set Fair Value